Screener
Aurinia Pharmaceuticals AUPH Gross Carrying Amount
Gross Carrying Amount at other companies
Other financials
Where this comes from
Reported directly by Aurinia Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsGross.
The source filing: Aurinia Pharmaceuticals’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 8:16 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001600620-26-000062
| Line item | Gross Carrying Value | Accumulated Amortization | Net Carrying Amount |
|---|---|---|---|
| Acquired intellectual property and reacquired right | $15,126 | $(12,732) | $2,394 |
| Patents | 2,419 | (1,435) | 984 |
| Internal-use software implementation costs | 2,873 | (2,873) | — |
| Total intangible assets, net | $20,418 | $(17,040) | $3,378 |
Item 1. Financial Statements.
FAQ
- What is Aurinia Pharmaceuticals's gross carrying amount?
- Aurinia Pharmaceuticals (AUPH) reported gross carrying amount of $20.42M in Q2 2026.
- How has Aurinia Pharmaceuticals's gross carrying amount changed year-over-year?
- Aurinia Pharmaceuticals's gross carrying amount increased by 0.9% year-over-year, from $20.24M to $20.42M.
- What is the long-term trend for Aurinia Pharmaceuticals's gross carrying amount?
- Over 5 years (2020 to 2025), Aurinia Pharmaceuticals's gross carrying amount has grown at a 2.0% compound annual growth rate (CAGR), from $18.45M to $20.38M.
- What does gross carrying amount mean?
- Gross Carrying Amount
Ask your AI about Aurinia Pharmaceuticals's gross carrying amount.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude